Edoxaban Versus Warfarin in Patients With Atrial Fibrillation and History of Liver Disease | Journal of the American College of Cardiology
Edoxaban: A New Oral Factor Xa Inhibitor Anticoagulant
Table 1 from Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2. | Semantic Scholar
SAVAYSA® (edoxaban) Dosing for Patients | HCP Site
The Potential Role of Edoxaban in Stroke Prevention Guidelines | AER Journal
Overview of edoxaban dose adjustment criteria. | Download Scientific Diagram
SAVAYSA® (edoxaban) Dosing for Patients | HCP Site
Pharmaceuticals | Free Full-Text | Clinical Evidence for the Choice of the Direct Oral Anticoagulant in Patients with Atrial Fibrillation According to Creatinine Clearance
Randomized, Double-Blind Comparison of Half-Dose Versus Full-Dose Edoxaban in 14,014 Patients With Atrial Fibrillation - ScienceDirect
Edoxaban - wikidoc
EDOXABAN
Efficacy of higher-dose edoxaban in the intention-to-treat population... | Download Scientific Diagram
Anticoagulant Therapy – Options, Dosing and Risks
Lixiana Full Prescribing Information, Dosage & Side Effects | MIMS Philippines
Edoxaban Exposure in Patients With Atrial Fibrillation and Estimated Creatinine Clearance Exceeding 100 mL/min - Yin - 2022 - Clinical Pharmacology in Drug Development - Wiley Online Library
Edoxaban: An Update on the New Oral Direct Factor Xa Inhibitor | SpringerLink
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial - The Lancet
Lixiana Dosage/Direction for Use | MIMS Hong Kong
Factors associated with the dosing of edoxaban for stroke pr... : Journal of the Chinese Medical Association
Pharmacology of oral anticoagulant edoxaban and clinical implications - PACE-CME
SAVAYSA® (edoxaban) Dosing | HCP
